Oral antiplatelet therapy in acute coronary syndromes: What do current guidelines say?

Oral antiplatelet therapy has a pivotal role in the treatment of acute coronary syndromes (ACS). Recent advances in the field of oral antiplatelet agents have led to guideline updates and changed the clinical practice of treating patients with ACS. This review summarizes the up-to-date recommendatio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Türk Kardiyoloji Derneği arşivi 2015-10, Vol.43 Suppl 2, p.13-19
1. Verfasser:	Aydoğdu, Sinan
Format:	Artikel
Sprache:	tur
Schlagworte:	Acute Coronary Syndrome - drug therapy Administration, Oral Humans Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - therapeutic use Practice Guidelines as Topic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Oral antiplatelet therapy has a pivotal role in the treatment of acute coronary syndromes (ACS). Recent advances in the field of oral antiplatelet agents have led to guideline updates and changed the clinical practice of treating patients with ACS. This review summarizes the up-to-date recommendations of current guidelines regarding the use of oral antiplatelet agents in the setting of ACS.
ISSN:	1016-5169